Can Shi
- Immunology and Allergy top 5%
- Cell Adhesion Molecules Research 8
- Immunology top 5%
- Immune Response and Inflammation 7
- Hematology top 2%
- Platelet Disorders and Treatments 4
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 9
- MicroRNA in disease regulation 8
- Protease and Inhibitor Mechanisms 3
- Internal Medicine top 5%
-
- Circular RNAs in diseases 8
- S100 Proteins and Annexins 3
- Co-authors
- Daniel I. SimonMasashi SakumaYunmei WangKevin CroceHuiyun GaoAlexandre C. ZagoPeter LibbyZhiping Chen
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Can Shi
41 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 104
- Immunology and Allergy 203
- Immunology 690
- Hematology 355
- Cancer Research 417
- Internal Medicine 71
Countries citing papers authored by Can Shi
This map shows the geographic impact of Can Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Can Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Can Shi more than expected).
Fields of papers citing papers by Can Shi
This network shows the impact of papers produced by Can Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Can Shi. The network helps show where Can Shi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Can Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 6 | |
| 4 | 2022 | 10 | |
| 5 | 2019 | 14 | |
| 6 | 2019 | 18 | |
| 7 | 2019 | 9 | |
| 8 | 2018 | 85 | |
| 9 | 2017 | 22 | |
| 10 | 2017 | 127 | |
| 11 | 2017 | 20 | |
| 12 | 2015 | 30 | |
| 13 | 2015 | 46 | |
| 14 | 2014 | 16 | |
| 15 | 2009 | 202 | |
| 16 | 2008 | 14 | |
| 17 | 2008 | 81 | |
| 18 | 2006 | 37 | |
| 19 | 2004 | 72 | |
| 20 | 1995 | 1 |
About Can Shi
Can Shi is a scholar working on Immunology and Allergy, Cancer Research and Immunology, having authored 43 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (8 papers), Circular RNAs in diseases (8 papers), Cell Adhesion Molecules Research (8 papers), Immune Response and Inflammation (7 papers), Platelet Disorders and Treatments (4 papers), Protease and Inhibitor Mechanisms (3 papers) and S100 Proteins and Annexins (3 papers). The work is most often cited by research in Immunology and Allergy (203 citations), Immunology (690 citations) and Hematology (355 citations). Can Shi has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Daniel I. Simon, Masashi Sakuma, Yunmei Wang, Kevin Croce, Huiyun Gao, Alexandre C. Zago, Peter Libby, Zhiping Chen, Zhiping Chen and Yue Dai. Their work appears in journals such as Cell Research, Circulation, Journal of Clinical Investigation, Arteriosclerosis Thrombosis and Vascular Biology and Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.